Exagen targets $72M-$75M 2026 revenue outlook as profitability nears breakeven — See source for full details.
$XGN
Price history, market instrument context, member research, and related headlines in one place.
XGN key statistics
NasdaqGMUSD
52-week range
$2.5960%$12.23
Latest session $8.32–$9.21Exagen Inc. (XGN) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $8.42, down $0.06 (0.71%) from the previous close of $8.48. It has traded between $8.32 and $9.21 in the latest session. Over the past year it has ranged from $2.59 to $12.23, leaving it in the upper half of its 52-week range (60%). Reported volume for the session was 611.8K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Exagen Q2 2026 slides: record revenue, stock surges 30% on results — See source for full details.
Loading $XGN research…